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Summary Malotilate (diisopropyl,1 ,3-dithiol-2-ylidenemalonate, MT) isclinically used as a hepatoprotective agent. Because we noticed that MT
induced the differentiation of cultured vascular endothelial cells, we have examined its effects on lung metastasis of the highly metastatic rat
mammary carcinoma c-SST-2. MT was orally administered to syngeneic SHR rats from 7 days before or after s.c. inoculation of c-SST-2 cells
to the end of the experiments. In the MT-treated rats, pulmonary metastasis was markedly suppressed compared with the non-treated rats. In
the rats treated with MTfor 19 days after i.v. inoculation ofc-SST-2 cells, lung metastasis was also significantly suppressed. An in vitro invasion
assay using a rat lung endothelial (RLE) cell monolayer revealed that pretreatment of the RLE cells with MT, but not c-SST-2 cells, significantly
reduced the invasion of the RLE monolayer by c-SST-2 cells. An in vitro vascular permeability assay demonstrated that MT prevented the
increase in permeability of the RLE monolayer by serum starvation. On the other hand, in vivo and in vitro growth, gelatinase production and
adhesion to the RLE cell monolayer of c-SST-2 cells were not affected by MT treatment. These findings suggest that MT suppressed tumour
metastasis by intensifying the cell-to-cell contact of endothelial cells, thus preventing tumour cells from invading vascular endothelium.
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Most malignant tumour cells are capable of metastasizing to
distant organs. This property of the malignant cells is responsible
for most human cancer deaths, despite advances in surgery, radio-
therapy and chemotherapy. Prevention of cancer metastasis is
therefore a major objective of cancer research. The metastatic
process of cancer is a series of sequential steps in which tumour
cells are released from the primary tumour and disseminate to
distant organs, where they proliferate to form new tumour
foci (Poste and Fidler, 1980; Liotta, 1988; Nicolson, 1988).
Interactions of malignant cells with endothelial cells or sub-
endothelial basement membrane play an important role in the
establishment ofblood-borne metastasis (Nicolson, 1989; Pauli et
al, 1990). The malignant cells meet with endothelium when they
intra- or extravasate. In case of intra- or extravasation, tumour
cells have to invade the endothelial cell monolayer and subendo-
thelial basement membrane (Nicolson, 1982; Liotta, 1986). In a
sense, endothelium acts as afort toblood-borne metastasis. In fact,
peptides or antibodies that are able to block the adhesion of
tumour cells to endothelium inhibit metastasis by rodent cancer
cells (Humphries et al, 1986; Iwamoto et al, 1987; Saiki et al,
1989; Fujita et al, 1992). The repression of matrix degradative
activity by proteinase inhibitors, such as tissue inhibitor of matrix
metalloproteinase (TIMP), plasminogen activator inhibitor (PAI),
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urinary trypsin inhibitor and so on, lead a decrease in metastasis
and in vitro invasion of reconstituted basement membrane by
metastatic tumour cells (Schultz et al, 1988; Alvarez et al, 1990;
Khokha, 1994; Kobayashi et al, 1995; Mueller et al, 1995). In
addition, the ability of tumour cells to induce retraction of the
endothelial cell monolayer is one ofthe most important properties
in intra- or extravasation. A drug that prevents tumour cells from
inducing retraction of the endothelial cell layer is also a good
candidate for an antimetastatic agent.
Malotilate (MT), diisopropyl-1,3-dithiol-2-ylidenemalonate
(Mr 288.38), is in clinical use as a hepatoprotective agent. It has
already been demonstrated in experiments using animal models
that MT protects the liver against acute and chronic injuries
induced by toxins and reduces hepatic fibrosis (Kato and
Sugimoto, 1982; Nokata et al, 1985; Ryle and Dumont, 1987). MT
is known to increase RNA and protein synthesis by hepatocytes
(Imaizumi, 1982a and b; Wakasugi and Tomikawa, 1987).
Furthermore, it also modifies the functions of endothelial cells,
fibroblasts ormacrophages (Ryle and Dumont, 1987; Zijlstra et al,
1989; Sunada et al, 1993). For example, it was observed recently
that MT with phosphoascorbic acid was effective for maintaining
the cobblestone-shape monolayer of cultured bovine aortic
endothelial cells for a long time and it developed various junc-
tional apparates (Sunada et al, 1993). This observation led us to
speculate on the protective effects of MT on the retraction of the
endothelial monolayer by tumour cells. Therefore, we examined
its possible inhibitory effects on the haematogenous metastasis of
a highly metastatic rat mammary carcinoma.
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(C12H1604S2, Mr 288.38) was prepared by Nihon Nohyaku
(Kawachinagano, Japan). The structure is as shown in Figure 1.
Animals
SHR rats were obtained from Nippon Rat (Urawa, Japan). Female
SHR rats aged 7-10 weeks were used throughout the experiments.
Tumour cells and rat endothelial cells
The tumour cell line c-SST-2 was established from a mammary
adenocarcinoma spontaneously developed in an SHR rat (Hamada
et al, 1988). The c-SST-2 cells possessed highly metastatic poten-
tial to lungs in syngeneic rats after s.c. or i.v. injection. This cell
line was grown on tissue culture dishes in Eagle's minimum essen-
tial medium (MEM) supplemented with 7% fetal bovine serum
(FBS). Rat lung endothelial (RLE) cells were kindly provided by
Dr GL Nicolson (MD Anderson Cancer Center, Houston, TX,
USA) (Nakajima et al, 1989). RLE cells were grown on gelatin-
coated tissue culture dishes in Dulbecco's modified MEM (DME)
supplemented with 10% FBS (ENDO medium).
Inoculation of c-SST-2 cells and administration of
malotilate
MT was dissolved to be a 6% or 3% solution with 1% gum arabic
solution. Three hundred milligrams or 150 mg kg-' body weight or
1% gum arabic solution as vehicle control was given daily orally
by means of Nelaton's catheter. For spontaneous metastasis assay,
MT administration was started 7 days before or after s.c. inocula-
tion with c-SST-2 cells (1 x 105 or 2 x 105) in the right back of
syngeneic SHR rats and continued until the 28th or 30th day after
the tumour inoculation. The mean tumour diameter of individual
tumours, measured with callipers, was calculated from measure-
ments of two planes at right angles. The rats were killed on the
35th day after the tumour inoculation and examined for metas-
tases. Pulmonary metastases were estimated by macroscopically
counting the numbers of metastatic nodules on the lung surface
after fixation oflungs with Bouin's solution.
For experimental metastasis assay, SHR rats were orally admin-
istered MT (300 mg kg-' day-') for 7 days before and for 19 days
after i.v. injection with c-SST-2 cells (5 x 104) into the tail vein.
Twenty days after the tumour injection, the rats were killed and
examined for metastases. Pulmonary metastatic nodules were
counted as described above.
Table 1 Inhibitory effects of malotilate on pulmonary metastasis of c-SST-2
rat mammary carcinoma cells in SHR rats
Dose of malotilate Pulmonary metastasis
(mg kg-lp
Incidence Lung weight Number of metastatic
(g ± s.d.) foci (mean ± s.d.)
Spontaneousmetastasisb
oc 5/5 3.6±1.5 TNTC
150 5/5 1.5+0.1* 1.3±1.5**
300 5/5 1.4 ±0.1 * 2.4 ± 2.4**
Spontaneous metastasisd
Oe 5/5 2.0+0.2 96.2± 11.1
oc 5/5 2.0±0.1 100.6±18.5
150 5/5 1.4 +0.2** 30.8 ± 11.6**
300 5/5 1.2 +0.1* 16.4 ±7.6**
Experimental metastasis'
oc 5/5 2.3± 0.2 133.4+ 35.6
150 5/5 1.9±0.5 93.2±27.1
300 5/5 1.6 ± 0.5* 73.6 + 27.9*
aMalotilate or gum arabic vehicle was p.o. administered daily throughout the
experiment. bc-SST-2 cells (1 x 105) were inoculated s.c. into SHR rats; the
rats were killed and were examined for metastasis 35 days after the tumour
inoculation. c1% Gum arabic vehicle control. dc-SST-2 cells (2 x 105) were
s.c. inoculated into SHR rats. Malotilate administration started at 7 days after
the tumour inoculation. The rats were killed and were examined for
metastasis 30 days after the tumour inoculation. eThe rats were given neither
malotilate nor gum arabic vehicle. 'c-SST-2 cells (1 x 105) were i.v. injected
into the tail vein of SHR rats; the rats were killed and were examined for
metastasis 21 days after the tumour injection. *P< 0.05, ** P< 0.01
compared with non-treated control (gum arabic vehicle) group, by Student's
t-test. TNTC (too numerous to count) was estimated as 200 foci.
Assay for in vitro growth of c-SST-2 and RLE cells
c-SST-2 and RLE cells (1 x 106 per dish) were seeded on 100-mm
tissue culture dishes in DME supplemented with 7% FBS and then
treated with various concentrations of MT for 24 h. The cells
(5 x 104 per well) pretreated with or without MT were transferred
into 24-well plates. The cells were chronologically harvested and
counted with a haemocytometer. In another experiment, the cells
(5 x 104 per well) were seeded on 24-well plates in DME supple-
mented with 7% FBS, and simultaneously various concentrations
of MT was added into each well. The cells were chronologically
harvested and counted with a haemocytometer.
Assay for in vitro chemoinvasion of reconstituted
basement membrane, Matrigel, by c-SST-2 cells
In vitro tumour cell invasion was assayed according to the method
reported by Albini et al (1987) with some modification. Briefly,
membranes with 8-pm pores of Transwell chambers (Costar,
Cambridge, MA, USA) were coated with ,l of 20 times diluted
Matrigel (Collabrative Research, Bedford, MA, USA) in cold DME.
The Matrigel-coated Transwell chambers were dried under a hood
overnight. The Matrigel was washed twice with 100g1 ofDME and
incubated with DME for 1 h at room temperature. Before the assay,
the medium in the uppercompartmentoftheTranswell chamber was
removed, and then 600,ul of medium conditioned with skin fibrob-
lasts from a new-born SHR rat was placed into the lower compart-
ment of the Transwell chamber as a chemoattractant, and 50g1
of c-SST-2 cell suspension (4 x I05 ml-) in DME supplemented
































Figure 2 In vivo growth of c-SST-2 tumours in SHR rats administered
malotilate. SHR rats were p.o. administered malotilate at doses of 0 (0,
1% gum arabic vehicle control; 0, no vehicle control), 150 (-) or 300 (A)
mg kg-' day-'. (A) MT administration was started 7 days before the c-SST-2
cell inoculation. (B) MT administration was started 7 days afterthe c-SST-2
cell inoculation. Each group consisted of five rats. Data are expressed as
mean ± s.d.
with 1% FBS and 50gl of DME with (200, 40, 8, 1.6ng ml-')
or without MT were placed into the upper compartment of the
chamber. After a 3-day incubation, each membrane was fixed with
10% neutral-buffered formalin and stained in Giemsa solution. After
thecells attached tothe uppersideofthemembrane wereremovedby
wiping with a cotton swab, those attached to the lower side of the
membrane were counted using a microscope. Invasiveness was eval-
uated by the numberofcells penetrating through the membrane.
Assay for in vitro invasion of the rat lung endothelial
cell (RLE) monolayer by c-SST-2 cells
Invasion of endothelial cell monolayer by c-SST-2 cells was
assayed in accordance to the method by Ohigashi et al (1989) with
some modification. RLE cells were seeded on gelatin (1%)-coated
tissue culture dishes with grids. When the cells reached conflu-
ency, the culture medium was replaced with fresh medium with or
without various concentrations ofMT. After a 24-h incubation, the
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Figure 3 Effects of malotilate on in vitro invasion of the rat lung endothelial
(RLE) cell monolayer and reconstituted basement membrane. (A) Invasion of
the RLE cell monolayer treated with malotilate by c-SST-2 cells. (B) Invasion
of the RLE cell monolayer by c-SST-2 cells treated with malotilate.
(C) Invasion of reconstituted basement membrane, Matrigel, by c-SST-2 cells
treated with malotilate. *P < 0.01 compared with the non-treated RLE cell
monolayer with malotilate, by Student's t-test
with or without MT for 24 h were cultured on overlayered RLE
cells for 7 days. The invasion capacity of c-SST-2 cells was
measured by counting the number of colonies per 1 cm2 formed
under the RLE monolayer using a phase contrast microscope.
Assay for adhesion of c-SST-2 cells to the rat lung
endothelial cell monolayer
Adhesion of c-SST-2 cells to the RLE monolayer was assayed
according to the method by Izumi et al (1995). When RLE cells
seeded on 24-well plates in ENDO medium reached confluency,
various concentrations of MT were added into the wells for 24 h.
c-SST-2 cells treated with or without MT for 24 h were detached
from culture dishes by treatment with 2 mm EDTA in PBS (-) and
suspended in DME containing 5% FBS. 3'-O-acetyl-2',7'-
bis(carboxyethyl)-4 or 5-carboxyfluorescein diacetoxymethylester
(BCECF-AM) was added to the cell suspension at a final concen-
tration of 3 gM. The cell suspensions were incubated at 370C for
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30 min and then rinsed three times with DME. Labelled tumour
cells were suspended in DME containing 1% bovine serum
albumin (BSA) at a density of 2 x 105 cells ml-'. The cell suspen-
sions (0.5 ml per well) were placed in RLE culture plate prepared
as above. After 10, 20, 30, 60 and 120 min of incubation in a
carbon dioxide incubator, the cultures in triplicate cells were
washed three times with DME; the attached cells were lysed in 1%
Triton X-100 at 37°C. The fluorescence intensity of the lysates
was measured under excitation at 490 nm and emission at 520 nm
using a spectrofluorimeter (Model LS 50B, Perkin Elmer,
Buckinghamshire, UK). Adhesion rates were evaluated as % [fluo-
rescence intensity of lysates of attached cells/fluorescence inten-
sity oflysates ofinitial seeded cells (1 x 105 labelled cells)] x 100.
Zymography for gelatinase of c-SST-2 cells
Tumour cells (2 x 105 per well) were cultured on a 12-well tissue
culture plate in DME supplemented with 7% FBS overnight. The
culture was washed twice with DME and 1 ml ofDME was added
to each well. After a 24-h incubation, supematants were collected,
centrifuged at 800g for 10 min and recentrifuged at 20 000g for
1 h. The serum-free samples were mixed with sample buffer at 2:1
and loaded on a sodium dodecyl sulphate (SDS)-gelatin-
embedded gel (0.75 mm thickness) prepared using previously
published procedures (Nakajima et al, 1989).
Electrophoresis was carried out using Laemmli's method under
cooling conditions (Laemmli, 1970). After the electrophoresis, the
gel was rinsed with 2.5% Triton X-100 in 50 mm Tris-HCl buffer
(pH 7.5) containing 0.05% sodium azide on a rocker platform at
room temperature for 1.5 h. The gel was incubated at 37°C for
24 h in 0.15 M sodium chloride, 1O mM calcium chloride and
50 mM Tris-HCl buffer (pH 7.5) containing sodium azide. After
the incubation, the gel was stained with 0.05% Coomassie Blue R-
250 in isopropanol-acetic acid-water (1:1:8), destained with
isopropanol-acetic acid-water (1:1:8). Gelatinolytic enzymes
were detected as transparent bands on the blue background of a
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Assay for permeability of rat lung endothelial cell
monolayer
RLE cells (5 x 104) suspended in 100 ,l of ENDO medium were
seeded onto gelatin-coated (1% gelatin, 30 min) membranes with
0.4-gm pores of Transwell chambers. The ENDO medium
(600gl) was also placed into the lower compartment ofthe cham-
bers. After a 24-h incubation, the media in both compartments
were removed and DME containing various concentrations ofMT
and 4% FBS were added into both compartments. The cultures
were incubated for 24 h and then washed twice with DME. In the
experiment under serum-starved conditions, fresh DME was
placed into both the upper and the lower compartments of the
chamber. As non-serum-starved control, DME supplemented with
4% FBS was placed instead of DME. In the experiment under co-
culture with tumour cells, c-SST-2 cells (500 cells per 0.1 ml of
DME supplemented with 4% FBS) were overlayed onto the RLE
monolayer and DME supplemented with 4% FBS was placed into
the lower compartment. For assessment of permeability, 10 ,l of
FITC-dextran (=70 kDa, 10 mg ml-', Sigma, St Louis, MO, USA)
in DME was added into the upper compartment and the cultures
were incubated for 6 h. The media in the lower compartments
were transferred into a 96-well microtitre plate (100gl per well)
for measuring fluorescence. Fluorescence intensity was measured
using a spectrofluorimeter (Corona Electric, Hitachinaka, Japan)
at 490 nm (excitation) and 530 nm (emission).
RESULTS
Inhibitory effects of malotilate on pulmonary
metastasis of c-SST-2 cells
As shown in Table 1, the numbers of pulmonary metastatic
nodules and lung weight of the rats treated with malotilate (MT)
were significantly reduced compared with those ofthe non-treated
rats when c-SST-2 cells had been inoculated subcutaneously 7
days before MT administration. Next, we examined the effects of
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Figure 4 Effects of malotilate on the permeability of the rat lung endothelial (RLE) cell monolayer. Inhibition of the increase in permeability of the RLE cell
monolayer induced by serum-free culture conditions (A) or co-culture with c-SST-2 cells (B). Data are expressed as mean ± s.d. from triplicate assay. *P< 0.01
compared with permeability of the RLE cell monolayer treated without malotilate, by Student's t-test. **P < 0.05, ***P < 0.01 compared with permeability of the
RLE monolayer treated without malotilate when co-cultured with c-SST-2 cells, by Student's t-test
British Joumal ofCancer (1998) 77(9), 1371-1377
.?
T-T
0CancerResearch Campaign 1998Antimetastatic effect ofmalotilate 1375
tumour. MT administration was started 7 days after the c-SST-2
cell inoculation when primary tumours had already developed
(Figure 2B). Like the result from pretreatment of MT, pulmonary
metastasis was significantly inhibited in the rats administered
with MT compared with non-treated or vehicle control rats.
Experimental pulmonary metastasis was also significantly reduced
in the MT-treated rats (300 mg kg-1 day-') compared with the non-
treated rats. On the other hand, when tumour cells had been s.c.
inoculated, the tumour growth in primary sites was not affected by
the treatment with MT (Figure 2).
Effects of malotilate on in vitro invasion of the rat lung
endothelial cell monolayer and reconstituted basement
membrane, Matrigel
When c-SST-2 cells were pretreated with MT for 24 h, their inva-
sion ofboth RLE cell monolayer and Matrigel did not differ from
that of the non-treated (Figure 3B and C). In contrast, when RLE
cells were pretreated with MT for 24 h, the invasion of the RLE








Effects of malotilate on the permeability of the rat lung
endothelial cell monolayer
The permeability of the RLE monolayer increased by serum star-
vation when RLE cells seeded on the gelatin-coated membrane of
Transwell reached confluence. Pretreatment ofthe RLE cell mono-
layer with more than 20 ng ml-' ofMT for 24 h led to inhibition of
the increase in the permeability by serum starvation to the perme-
ability level of the non-serum-starved RLE monolayer (Figure
4A). The increase in the permeability of the RLE cell monolayer
by co-culturing with c-SST-2 cells was also inhibited by pretreat-
ment with MT (Figure 4B).
Effects of malotilate on in vitro growth, gelatinase
production and adhesion to the rat lung endothelial cell
monolayer by c-SST-2 and RLE cells
In vitro growth of c-SST-2 or RLE cells was not affected by
pretreatment with MT for 24 h (data not shown). The adhesion of
c-SST-2 cells to the RLE monolayer was not affected by the
pretreatment of c-SST-2 cells or RLE cells with MT (Figure 5A).
Furthermore, adhesion of c-SST-2 cells pretreated with malotilate
to the RLE cell monolayer also pretreated with malotilate was
examined in the presence of the same concentration of molotilate
as the pretreatment. As shown in Figure 5B, the adhesion rate ofc-
SST-2 cells to the RLE monolayer was almost the same even if
Malotilate was present during the adhesion assay. By zymographic
analysis, 92-kDa, 67-kDa and 64-kDa enzymatic bands were
detected in medium conditioned with c-SST-2 cells, and the
production ofthese gelatinases was not changed by MT treatment
(Figure 6). No gelatinolytic activity was detected in medium
conditioned with RLE cells treated with or without MT.
DISCUSSION
We showed here that malotilate (MT), which has been used clini-
cally for liver disease, in stimulating liver functions, demonstrated
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Figure 5 Influence of malotilate on in vitro adhesion of c-SST-2 cells to the
rat lung endothelial (RLE) cell monolayer. (A) c-SST-2 (open symbols) or
RLE (closed symbols) cells were treated with malotilate for 24 h at
concentrations of 0 (0), 10 (A, A) or 100 (b, *) ng ml-' before the adhesion
assay. (B) Both c-SST-2 and RLE cells were pretreated with malotilate for
24 h at concentrations of 0 (0), 4 (0), 20 (A) or 100 (U) ng ml-1, and then
the adhesion assay was performed in the presence of malotilate at the same
concentration as the pretreatment. Data are expressed as mean ± s.d. from
triplicate assay
Malotilate 0 1 10 100 0 1 10 100
(ng ml-1)
c-SST-2 RLE
Figure 6 Gelatinase production of c-SST-2 or the rat lung endothelial cells
treated with malotilate. Gelatinase production was detected by zymography
using gelatin-embedded SDS-PAGE as described in Materials and methods
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growth ofc-SST-2 rat mammary carcinoma cells. The treatment of
c-SST-2 cells with MT did not modify their metastasis-associated
properties, such as adhesion and invasion into the RLE endothelial
cell monolayer or basement membrane, gelatinase production and
migration activity. On the other hand, the in vitro invasion of the
RLE monolayer by c-SST-2 cells was inhibited by treatment of
RLE but not c-SST-2 cells with MT. Therefore, it seems that MT
acts on endothelial cells but not on tumour cells to inhibit metas-
tasis. The inhibitory effect of MT on the in vitro invasion of the
RLE monolayer by c-SST-2 cells may be partly because MT
prevents the retraction of the RLE monolayer, as MT treatment
suppresses the increase in permeability of the RLE monolayer by
serum starvation or co-culture with c-SST-2 cells. These findings
suggest that MT acts on endothelial cells to intensify the cell adhe-
sion among endothelial cells, which prevents c-SST-2 cells from
penetrating through the endothelium.
The inhibitory effect on the experimental metastasis was less
than that on spontaneous metastasis. The difference in the effect
between experimental metastasis and spontaneous metastasis
systems may be caused by the following: (1) in i.v. inoculation of
tumour cells, a large number oftumour cells may be circulated at a
time, which provides more chances to extravasate endothelium;
(2) in the spontaneous metastasis system, tumour cells need to
twice penetrate the endothelium that blocks their way, whereas in
the experimental metastasis system they need it only once. Thus,
inhibitory effects of MT on metastasis may differ depending on
inoculation routes oftumour cells.
The mechanism by which MT intensifies cell-cell adhesion
among endothelial cells is not clear. It is reported that MT stimu-
lates RNA and protein syntheses and glucose metabolism in the
liver and the cultured hepatocyte (Imaizumi, 1982a and b;
Wakasugi and Tomikawa, 1987). It is also known that MT modu-
lates the functions of various types ofcells other than hepatocytes
(Ryle and Dumont, 1987; Zijlstra et al, 1989; Sunada et al, 1993).
In fact, we have observed electron microscopically that MT
promoted the development ofcell-cell adhesion apparates, such as
gap junctions and desmosomes (unpublished data). Further, we
have data indicating that the expression of connexin 43 proteins,
which are components of gap junctions, is enhanced in RLE cells
by MT treatment (unpublished data). Sunada et al (1993) also
reported that MT preserved the cobblestone-shaped cell mono-
layer of bovine endothelial cells for a long-term culture and
promoted the formation of adherence junctions and gap junctions
between endothelial cells. Therefore, we speculate that MT may
stimulate endothelial cells to synthesize proteins, including the
molecules involved in homophilic cell-cell adhesion.
Regarding the inhibitory effect ofMT on increased permeability
of the RLE monolayer caused by co-culture with tumour cells, we
also need to consider another possibility besides the intensifying
effect of MT on cell adhesion among endothelial cells. Enhanced
permeability of the endothelial cell monolayer by co-culture with
tumour cells may be due to endothelial cell retraction mediated
by the interaction of endothelial cells with the tumour cells.
Endothelial cell retraction is known to be induced by soluble
factors or direct adhesion of other types of cells from which intra-
cellular signals are transduced to induce morphological changes of
cells and to reduce adhesiveness among endothelial cells (Tang et
al, 1993a and b). Therefore, the possibility remains that MT may
block the signal transduction involved in endothelial cell retraction,
besides intensification ofadhesiveness among endothelial cells.
There are some reports that the blockage of the interaction
between tumour cells and endothelium in target organs leads to the
inhibition ofmetastasis in animal models. For example, anti-adhe-
sive pepetides based on the amino acid sequence RGDS or YIGSR
are able to block the adhesion of tumour cells to subendothelial
basement membrane components, resulting in anti-metastatic
effects (Humphries et al, 1986; Iwamoto et al, 1987; Saiki et al,
1989). Antibodies to integrins are also known to have similar
metastasis-inhibitory effects (Fujita et al, 1992; Kawaguchi et al,
1992). One of the mechanisms for the anti-metastatic action of
protease inhibitors, such as tissue inhibitor of metalloproteinase
(TIMP) and plasminogen activator inhibitor (PAI), is thought to
prevent intra- or extravasation of tumour cells by inhibition of the
degradation ofthe basement membrane (Schultz et al, 1988; Cajot
et al, 1990; Albini et al, 1991; Khokha et al, 1992). Anti-angio-
genic agents may also be recognized as a blocker of the tumour
cell-endothelium interaction to suppress the growth of metastatic
foci (Ingber et al, 1990; O'Reilly et al, 1994). Compared with
these anti-metastatic agents, MT is unique for its mechanism of
action as it enhances the defensive ability of endothelial cells
against the penetration by metastatic tumour cells but does not
modify the offensive properties of tumour cells per se to establish
metastases. As MT did not have any toxicity to SHR rats at the
doses used here, it may be potentially useful in the prevention of
cancer metastasis, probably being more effective in anti-metastasis
when in combination with other therapeutic drugs. However,
further study is needed to examine in detail the mechanisms ofthe
intensification ofadhesion among endothelial cells and to examine
the influence on the other host cells, such as the immune cells.
ABBREVIATIONS
MT, malotilate; ENDO medium, Dulbecco's modified MEM
(DME) supplemented with 10% FBS; RLE, rat lung endothelial cell
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